Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

AC Immune S.A. (ACIU)

AC Immune S.A. (ACIU)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 507,875
  • Shares Outstanding, K 71,937
  • Annual Sales, $ 16,460 K
  • Annual Income, $ -66,040 K
  • 60-Month Beta 0.80
  • Price/Sales 30.03
  • Price/Cash Flow N/A
  • Price/Book 2.08
Trade ACIU with:

Options Overview

Details
  • Implied Volatility 83.57%
  • Historical Volatility 46.41%
  • IV Percentile 0%
  • IV Rank 0.02%
  • IV High 373.30% on 09/21/20
  • IV Low 83.52% on 04/08/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 7
  • Volume Avg (30-Day) 113
  • Put/Call OI Ratio 0.60
  • Today's Open Interest 8,306
  • Open Int (30-Day) 3,449

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate -0.22
  • Number of Estimates 3
  • High Estimate -0.12
  • Low Estimate -0.28
  • Prior Year -0.10
  • Growth Rate Est. (year over year) -120.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.50 +4.00%
on 04/12/21
8.15 -17.06%
on 03/29/21
-1.16 (-14.65%)
since 03/16/21
3-Month
5.75 +17.57%
on 01/29/21
12.50 -45.92%
on 02/11/21
+0.83 (+14.00%)
since 01/15/21
52-Week
4.42 +52.94%
on 11/02/20
13.00 -48.00%
on 07/16/20
-0.88 (-11.52%)
since 04/16/20

Most Recent Stories

More News
AC Immune Hosts Investor Webinar Highlighting the Power of its Morphomer(TM) Platform to Enable Precision Medicine for Neurodegenerative Disease

AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, will host an investor webinar today to discuss the unique benefits...

ACIU : 6.75 (-4.39%)
AC Immune Reports Full-Year 2020 Financial Results and Provides 2021 R&D Outlook

AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today reported its financial results for the year ended December 31,...

ACIU : 6.75 (-4.39%)
AC Immune to Present New Data from Alpha-Synuclein and TDP-43 Programs at the AD/PD(TM) 2021 Virtual Conference

AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical-stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, today announced that four new data presentations will be...

ACIU : 6.75 (-4.39%)
Biotech Stock Roundup: REGN's Drug Approval & Pipeline Updates From AMGN, BLUE

The biotech sector was in focus last week with regulatory and pipeline updates from quite a few companies like Regeneron (REGN), Amgen (AMGN) and bluebird (BLUE).

REGN : 503.94 (+1.88%)
AMGN : 256.09 (+0.38%)
CRTX : 37.31 (-3.49%)
BLUE : 28.13 (-5.35%)
ACIU : 6.75 (-4.39%)
AC Immune to Highlight Promising Alzheimer's Vaccine at the SVB Leerink 10th Annual Global Healthcare Conference

AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical-stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, today announced that it will participate in the upcoming...

ACIU : 6.75 (-4.39%)
Thinking about buying stock in AC Immune, Sundial Growers, FSD Pharma, Intec Pharma, or Northern Dynasty Minerals?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ACIU, SNDL, HUGE, NTEC, and NAK.

NAK : 0.5283 (-8.91%)
ACIU : 6.75 (-4.39%)
HUGE : 1.5501 (-2.51%)
SNDL : 0.8211 (-3.40%)
NTEC : 3.88 (-2.02%)
AC Immune Initiates Clinical Study of First-in-class Diagnostic for Parkinson's Disease

AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical-stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, today announced that the first patient has been scanned...

ACIU : 6.75 (-4.39%)
Neurologist and Psychiatrist Prof. Johannes Rolf Streffer, MD Joins AC Immune SA as Chief Medical Officer

Prof. Streffer is an established authority on neuroscience and biomarker modalities

ACIU : 6.75 (-4.39%)
AC Immune (ACIU) Reports Q3 Loss, Tops Revenue Estimates

AC Immune (ACIU) delivered earnings and revenue surprises of -16.67% and 32.00%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

ACIU : 6.75 (-4.39%)
AC Immune: 3Q Earnings Snapshot

LAUSANNE, Switzerland (AP) _ AC Immune SA (ACIU) on Friday reported a third-quarter loss of $20.6 million, after reporting a profit in the same period a year earlier.

ACIU : 6.75 (-4.39%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

AC Immune SA is a biopharmaceutical company. It develops, discover and design novel, proprietary medicines for prevention, diagnosis and treatment of neurodegenerative diseases. The Company's pipeline includes Crenezumab, ACI-24, Anti-Tau antibody, Morphomer Tau, Tau-PET imaging agent, Morphomer Abeta...

See More

Key Turning Points

3rd Resistance Point 7.43
2nd Resistance Point 7.29
1st Resistance Point 7.17
Last Price 6.75
1st Support Level 6.91
2nd Support Level 6.77
3rd Support Level 6.65

See More

52-Week High 13.00
Fibonacci 61.8% 9.72
Fibonacci 50% 8.71
Fibonacci 38.2% 7.70
Last Price 6.75
52-Week Low 4.42

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar